1. Helicobacter pylori clearance and serum gastrin and pepsinogen I concentrations in omeprazole treatment of duodenal ulcer patients

   • C. T. Lee
   • B. I. T. Kuo
   • S. D. Lee

   CLINICAL TRIALS Pages: 817 - 820

2. Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers

   • S. D. Ferrara
   • R. Giorgetti
   • P. Palatini

   PHARMACODYNAMICS Pages: 821 - 827

3. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease

   • M. Cazzola
   • F. Calderaro
   • M. G. Matera

   PHARMACODYNAMICS Pages: 829 - 833

4. Statins and peripheral neuropathy

   • U. Jeppesen
   • D. Gaist
   • S. H. Sindrup

   PHARMACODYNAMICS Pages: 835 - 838

5. Effect of codeine on oro-cecal transit time in Chinese healthy volunteers in comparison with Caucasian subjects

   • Q.-Y. Yue
   • J. Hasselström
   • J. Säwe

   PHARMACOKINETICS AND DISPOSITION Pages: 839 - 842

6. Protein binding of piritramide: influence of various protein concentrations and the postoperative acute phase response

   • G. Wiesner
   • M. Gruber
   • K. Taeger

   Pharmacokinetics and disposition Pages: 843 - 845

7. Sibutramine pharmacokinetics in young and elderly healthy subjects

   • I. D. Hind
   • J. E. Mangham
   • R. W. Jones

   PHARMACOKINETICS AND DISPOSITION Pages: 847 - 849

8. Effect of itraconazole on cerivastatin pharmacokinetics

   • T. Kantola
   • K. T. Kivistö
   • P. J. Neuvonen

   PHARMACOKINETICS AND DISPOSITION Pages: 851 - 855

9. Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics

   • U. P. Masche
   • K. M. Rentsch
   • K. E. Fattinger

   PHARMACOKINETICS AND DISPOSITION Pages: 857 - 864

10. No clinically relevant effect of Iornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamics

    • U. P. Masche
    • K. M. Rentsch
    • K. E. Fattinger

    PHARMACOKINETICS AND DISPOSITION Pages: 865 - 868

11. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities

    • P. Fuchs
    • W. E. Haefeli
    • M. Wenk

    PHARMACOKINETICS AND DISPOSITION Pages: 869 - 876

12. Patterns of practice for acute myocardial infarction in a population from ten countries

    • F. Venturini
    • M. Romero
    • G. Tognoni

    PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 877 - 886

13. Computerized surveillance of adverse drug reactions in hospital: Implementation

    • M. Levy
    • T. Azaz-Livshits
    • K. Brune

    PHARMACOKINETICS AND PRESCRIPTION Pages: 887 - 892